Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up

NCT06143137 is registered in ClinicalTrials.gov with Artcline GmbH as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06143137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up
Lead sponsor
Artcline GmbH
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
February 28, 2030
Enrollment
142 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

severe sepsis